Cancer Care Ontario | Action Cancer Ontario

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

34 Results

Guidelines and Advice

The Role of HER2/neu in Systemic and Radiation Therapy for Women with Breast Cancer

Status: Archived
ID: 1-17

Dec 1969

Guidelines and Advice

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Status: Archived
ID: 2-23
Version: 2-23 Version 2

Oct 2015

Guidelines and Advice

Optimal Treatment Strategies for Localized Ewing's Sarcoma of Bone after Neoadjuvant Chemotherapy

Status: Current
ID: 11-6
Version: 2

Dec 1969

Guidelines and Advice

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Status: In-Review
ID: 2-4
Version: 3

Mar 2019

Guidelines and Advice

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Status: Current
ID: GL-7-A-2016-3

Dec 1969

Guidelines and Advice

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Status: In-Review
ID: GL END 7-3
Version: 4

Dec 1969

Guidelines and Advice

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Status: Current

Dec 1969

Guidelines and Advice

Position Statements for Nursing Practice in Cancer Care

Status: Current
Version: 2

Dec 1969

Guidelines and Advice

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Status: Current
ID: GL END 9-10
Version: 2

Dec 1969

Guidelines and Advice

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Status: In-Review
ID: 7-14
Version: 3

Dec 1969

Guidelines and Advice

Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

Status: Current
ID: N/A
Version: N/A

Mar 2019

Guidelines and Advice

Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario

Status: Current
ID: GL 5-3ORG
Version: 2

Dec 1969

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

The Role of HER2/neu in Systemic and Radiation Therapy for Women with Breast Cancer

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Optimal Treatment Strategies for Localized Ewing's Sarcoma of Bone after Neoadjuvant Chemotherapy

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Position Statements for Nursing Practice in Cancer Care

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Endorsement of the 2018 American Society of Clinical Oncology Treatment of Malignant Pleural Mesothelioma Guideline

Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario

Pages